Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease

Experimental Neurology

Volumn 218, Issue 2, 2009, Pages 286-292

  Reddy, P Hemachandra ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid beta; Amyloid precursor protein; Mitochondria

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALCIUM ION;

ALZHEIMER DISEASE; BRAIN CELL; BRAIN MITOCHONDRION; BRAIN TISSUE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL ENERGY; CELL FUNCTION; GENE EXPRESSION; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CHROMOSOME PAIRING; HUMANS; MICE; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; PEPTIDE FRAGMENTS;

EID: 67649803186     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.03.042     Document Type: Review

References (75)

1. Almeida C.G., Tampellini D., Takahashi R.H., Greengard P., Lin M.T., Snyder E.M., and Gouras G.K. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 20 (2005) 187-198
2. Anandatheerthavarada H.K., and Devi L. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease. Neuroscientist 13 (2007) 626-638 Dec
3. Anandatheerthavarada H.K., Biswas G., Robin M.A., and Avadhani N.G. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161 (2003) 41-54
4. Baloyannis S.J., Mauroudis I., Manolides S.L., and Manolides L.S. Synaptic alterations in the medial geniculate bodies and the inferior colliculi in Alzheimer's disease: a Golgi and electron microscope study. Acta Oto-laryngol. 30 (2008) 1-3
5. Barsoum M.J., Yuan H., Gerencser A.A., Liot G., Kushnareva Y., Gräber S., Kovacs I., Lee W.D., Waggoner J., Cui J., White A.D., Bossy B., Martinou J.C., Youle R.J., Lipton S.A., Ellisman M.H., Perkins G.A., and Bossy-Wetzel E. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 25 (2006) 3900-3911
6. Begley J.G., Duan W., Chan S., Duff K., and Mattson M.P. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72 (1999) 1030-1039
7. Benard G., Bellance N., James D., Parrone P., Fernandez H., Letellier T., and Rossignol R. Mitochondrial bioenergetics and structural network organization. J. Cell. Sci. 120 (2007) 838-848
8. Bertoni-Freddari C., Fattoretti P., Casoli T., Meier-Ruge W., and Ulrich J. Morphological adaptive response of the synaptic junctional zones in the human dentate gyrus during aging and Alzheimer's disease. Brain Res. 517 (1990) 69-75
9. Bezprozvanny I., and Mattson M.P. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 31 (2008) 454-463
10. Brown M.R., Geddes J.W., and Sullivan P.G. Brain region-specific, age-related, alterations in mitochondrial responses to elevated calcium. J. Bioenerg. Biomembr. 36 (2004) 401-406
11. Brown M.R., Sullivan P.G., and Geddes J.W. Synaptic mitochondria are more susceptible to Ca2+overload than nonsynaptic mitochondria. J. Biol. Chem. 281 (2006) 11658-11668
12. Brzyska M., and Elbaum D. Dysregulation of calcium in Alzheimer's disease. Acta Neurobiol. Exp. (Wars). 63 (2003) 171-183
13. Caspersen C., Wang N., Yao J., Sosunov A., Chen X., Lustbader J.W., Xu H.W., Stern D., McKhann G., and Yan S.D. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer'sdisease. FASEB J. 19 (2005) 2040-2041
14. Chandrasekaran K., Giordano T., Brady D.R., Stoll J., Martin L.J., and Rapoport S.I. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res. Mol. Brain Res. 24 (1994) 336-340
15. Chandrasekaran K., Hatanpää K., Brady D.R., and Rapoport S.I. Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. Exp. Neurol. 42 (1996) 80-88
16. Chan S.L., Mayne M., Holden C.P., Geiger J.D., and Mattson M.P. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J. Biol. Chem. 275 (2000) 18195-18200
17. Chan S.L., Culmsee C., Haughey N., Klapper W., and Mattson M.P. Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12. Neurobiol. Dis. 11 (2002) 2-19
18. Coskun P.E., Beal M.F., and Wallace D.C. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10726-10731
19. Crouch P.J., Blake R., Duce J.A., Ciccotosto G.D., Li Q.X., Barnham K.J., Curtain C.C., Cherny R.A., Cappai R., Dyrks T., Masters C.L., and Trounce I.A. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci. 25 (2005) 672-679
20. DeKosky S.T., Scheff S.W., and Styren S.D. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5 (1996) 417-421
21. Devi L., Prabhu B.M., Galati D.F., Avadhani N.G., and Anandatheerthavarada H.K. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26 (2006) 9057-9068
22. Diana A., Simić G., Sinforiani E., Orrù N., Pichiri G., and Bono G. Mitochondria morphology and DNA content upon sublethal exposure to beta-amyloid(1-42) peptide. Coll. Antropol.Suppl. 1 (2008) 51-58
23. Du H., Guo L., Fang F., Chen D., Sosunov A.A., McKhann G.M., Yan Y., Wang C., Zhang H., Molkentinm J.D., Gunn-Moore F.J., Vonsattel J.P., Arancio O., Chen J.X., and Yan S.D. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med. 14 (2008) 1097-1105
24. Eckert A., Hauptmann S., Scherping I., Rhein V., Muller-Spahn F., Götz J., and Muller W.E. Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodegener. Dis. 5 (2008) 157-159
25. Falkevall A., Alikhani N., Bhushan S., Pavlov P.F., Busch K., Johnson K.A., Eneqvist T., Tjernberg L., Ankarcrona M., and Glaser E. Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP. J. Biol. Chem. 281 (2006) 29096-29104
26. Furukawa K., Guo Q., Schellenberg G.D., and Mattson M.P. Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells. J. Neurosci. Res. 52 (1998) 618-624
27. Giacomello M., Drago I., Pizzo P., and Pozzan T. Mitochondrial Ca2+ as a key regulator of cell life and death. Cell Death Differ. 14 (2007) 1267-1274
28. Gibson G.E., Sheu K.F., and Blass J.P. Abnormalities of mitochondrial enzymes in Alzheimer disease. J. Neural Transm. 105 (1998) 855-870
29. Green K.N., and LaFerla F.M. Linking calcium to Abeta and Alzheimer's disease. Neuron 59 (2008) 190-194
30. Guo Q., Robinson N., and Mattson M.P. Secreted beta-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kappaβ and stabilization of calcium homeostasis. J. Biol. Chem. 273 (1998) 12341-12351
31. Gylys K.H., Fein J.A., Yang F., Wiley D.J., Miller C.A., and Cole G.M. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am. J. Pathol. 165 (2004) 1809-1817
32. Hansson Petersen C.A., Alikhani N., Behbahani H., Wiehager B., Pavlov P.F., Alafuzoff I., Leinonen V., Ito A., Winblad B., Glaser E., and Ankarcrona M. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 13145-13150
33. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., and Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21 (2001) 3017-3023
34. Huang H.M., Zhang H., Xu H., and Gibson G.E. Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation. Biochim. Biophys. Acta 1637 (2003) 119-126
35. Kaminsky Y.G., and Kosenko E.A. Effects of amyloid-beta peptides on hydrogen peroxide-metabolizing enzymes in rat brain in vivo. Free Radic. Res. 42 (2008) 564-573
36. Keil U., Bonert A., Marques C.A., Scherping I., Weyermann J., Strosznajder J.B., Muller-Spahn F., Haass C., Czech C., Pradier L., Muller W.E., and Eckert A. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J. Biol. Chem. 279 (2004) 50310-50320
37. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev., Neurosci. 3 (2002) 862-872
38. LaFerla F.M., Green K.N., and Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev., Neurosci. 8 (2007) 499-509
39. Leissring M.A., Akbari Y., Fanger C.M., Cahalan M.D., Mattson M.P., and LaFerla F.M. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149 (2000) 793-798
40. Li F., Calingasan N.Y., Yu F., Mauck W.M., Toidze M., Almeida C.G., Takahashi R.H., Carlson G.A., Beal M.F., Lin M.T., and Gouras G.K. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem. 89 (2004) 1308-1312
41. Lin M.T., Simon D.K., Ahn C.H., Kim L.M., and Beal M.F. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11 (2002) 133-145
42. Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N., Caspersen C., Chen X., Pollak S., Chaney M., Trinchese F., Liu S., Gunn-Moore F., Lue L.F., Walker D.G., Kuppusamy P., Zewier Z.L., Arancio O., Stern D., Yan S.S., and Wu H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304 (2004) 448-452
43. Manczak M., Park B.S., Jung Y., and Reddy P.H. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromol. Med. 5 (2004) 147-162
44. Manczak M., Anekonda T.S., Henson E., Park B.S., Quinn J., and Reddy P.H. Mitochondria are a direct site of Abeta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15 (2006) 1437-1449
45. Matsumoto K., Akao Y., Yi H., Shamoto-Nagai M., Maruyama W., and Naoi M. Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells. J. Neural Transm. 113 (2006) 125-135 2006 Feb
46. Mattson M.P. Secreted forms of beta-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25 (1994) 439-450
47. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
48. Mattson M.P. Calcium and neurodegeneration. Aging Cell 6 (2007) 337-350
49. Maurer I., Zierz S., and Möller H.J. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol. Aging 21 (2000) 455-462
50. Naga K.K., Sullivan P.G., and Geddes J.W. High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition. J. Neurosci. 27 (2007) 7469-7475
51. Norenberg M.D., and Rao K.V. The mitochondrial permeability transition in neurologic disease. Neurochem. Int. 50 (2007) 983-997
52. Núñez L., Senovilla L., Sanz-Blasco S., Chamero P., Alonso M.T., Villalobos C., and García-Sancho J. Bioluminescence imaging of mitochondrial Ca2+ dynamics in soma and neurites of individual adult mouse sympathetic neurons. J. Physiol. 580 (2007) 385-395
53. Park H.J., Kim S.S., Seong Y.M., Kim K.H., Goo H.G., Yoon E.J., Min d.o.S., Kang S., and Rhim H. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. J. Biol. Chem. 281 (2006) 34277-34287
54. Pascale A., and Etcheberrigaray R. Calcium alterations in Alzheimer's disease: pathophysiology, models and therapeutic opportunities. Pharmacol. Res. 39 (1999) 81-88
55. Praticò D. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol. Sci. 29 (2008) 609-615
56. Reddy P.H. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem. 96 (2006) 1-13
57. Reddy P.H. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons. Antioxid. Redox Signal. 9 (2007) 1647-1658
58. Reddy P.H. Mitochondrial medicine for aging and neurodegenerative diseases. Neuromol. Med. 10 (2008) 291-315
59. Reddy P.H., and Beal M.F. Are mitochondria critical in the pathogenesis of Alzheimer's disease?. Brain Res. Brain Res. Rev. 49 (2005) 618-632
60. Reddy P.H., and McWeeney S. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models. Neurobiol. Aging 27 (2006) 1060-1077
61. Reddy P.H., and Beal M.F. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med. 14 (2008) 45-53
62. Reddy P.H., and Manczak M. Neuroprotection of mitochondrial-targeted antioxidants in Alzheimer' disease. Paper presented at the Society for Neuroscience 2008 meeting held in Washington DC, November (2008) 15-19 Abstract #704.7
63. Reddy P.H., McWeeney S., Park B.S., Manczak M., Gutala R.V., Partovi D., Jung Y., Yau V., Searles R., Mori M., and Quinn J. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: upregulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum. Mol. Genet. 13 (2004) 1225-1240
64. Reddy P.H., Mani G., Park B.S., Jacques J., Murdoch G., Whetsell Jr. W., Kaye J., and Manczak M. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J. Alzheimers Dis. 27 (2005) 103-117
65. Sanz-Blasco S., Valero R.A., Rodríguez-Crespo I., Villalobos C., and Núñez L. Mitochondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PLoS ONE 3 (2008) e2718
66. Schmidt C., Lepsverdize E., Chi S.L., Das A.M., Pizzo S.V., Dityatev A., and Schachner M. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. Mol. Psychiatry 13 (2008) 953-969
67. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
68. Simonian N.A., and Hyman B.T. Functional alterations in Alzheimer's disease: selective loss of mitochondrial encoded cytochrome oxidase mRNA in the hippocampal formation. J. Neuropathol. Exp. Neurol. 53 (1994) 508-512
69. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., and Kowall N. Oxidative damage in Alzheimer's. Nature 382 (1996) 120-121
70. Stavrovskaya I.G., and Kristal B.S. The powerhouse takes control of the cell: is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death?. Free Radic. Biol. Med. 38 (2005) 687-967
71. Sultana R., Perluigi M., and Butterfield D.A. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signal. 8 (2006) 2021-2037
72. Swerdlow R.H. Treating neurodegeneration by modifying mitochondria: potential solutions to a complex problem. Antioxid. Redox Signal. 9 (2007) 1591-1603
73. Wang J., Xiong S., Xie C., Markesbery W.R., and Lovell M.A. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J. Neurochem. 93 (2005) 953-962
74. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., Wang Y., Casadesus G., and Zhu X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 19318-19323
75. Yoon Y.S., Yoon D.S., Lim I.K., Yoon S.H., Chung H.Y., Rojo M., Malka F., Jou M.J., Martinou J.C., and Yoon G. Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1. J. Cell. Physiol. 209 (2006) 468-480